Amarin (AMRN) vs Immuneering (IMRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Immuneering (IMRX) has outperformed Amarin (AMRN) over the past year, losing 36.8% versus a loss of 37.6%. Over five years, IMRX leads with a -84.5% price change compared with -88.4% for AMRN. Amarin is the larger company by market cap ($253.9 million vs $249.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AMRN | IMRX |
|---|---|---|
| Share price | $12.02 | $3.86 |
| Market cap | $253.90M | $249.73M |
| 1-day change | -0.41% | +0.78% |
| YTD return | -13.90% | -41.34% |
| 1-year return | -37.62% | -36.82% |
| 5-year return | -88.35% | -84.47% |
| Forward P/E | 12.27 | — |
| EPS (TTM) | $-1.20 | $-0.94 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $20.90 | $8.48 |
| 52-week low | $11.83 | $3.74 |
| Distance from 52-week high | -42.49% | -54.48% |
| Average volume | 66.03K | 693.70K |
| Shares outstanding | 21.12M | 64.70M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
AMRN vs IMRX FAQ
Which is bigger, Amarin or Immuneering?
Amarin (AMRN) is larger, with a market capitalization of $253.90M compared with $249.73M for Immuneering (IMRX).
Which stock has performed better over the past year, AMRN or IMRX?
IMRX returned -36.82% over the past 12 months, compared with -37.62% for AMRN (price return, excluding dividends). Past performance does not predict future results.
Are Amarin and Immuneering in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.